A recent study revealed that CBFβ-MYH11 maintains inv(16) leukemia by obstructing RUNX1-mediated repression of MYC expression, which is featured by the replacement of SWI/SNF for PRC1 at MYC distal enhancers9. Here, MYH11 is linked to leukemia.